Beijing-based genomics services provider Annoroad has completed a RMB700 million ($105 million) Series C round co-led by Shenzhen GTJA Investment Group and Ping An Ventures. SBCVC and SAIF Partners China also participated.
Founded in 2012, Annoroad provides next-generation sequencing-based (NGS) products and services for diagnostic use and life science research. They include genetic disease testing, diagnosis and treatment...
Swapping a traditional fund for a less familiar corporate vehicle represented a gamble for Equis, but the Asian infrastructure manager was confident its approach would make sense to a subset of investors
Taiwan’s technology sector must play an awkward balancing game amid US-China tensions. This could be a surprisingly favorable position for opportunistic investment and global diversifications
Chinese eye disease specialist Elumninex Biosciences has raised a $50 million Series A round led by GL Ventures, Lilly Asia Ventures (LAV), and Quan Capital.
Anacacia Capital has acquired a controlling stake in Pump Haircare, an Australian organic hair products brand that is looking to further expand its online distribution channels.